1 Canadian Healthcare Stock That’s My Defensive Growth Play

Well Health Technologies is seeing rapid growth as it brings the benefits of technology to the healthcare sector.

| More on:

Economic uncertainty always exists. And each time we’re in an elevated period of economic uncertainty, it seems like this time is different. But the fact is that economic uncertainty is the norm. Whether we realize it at the time or not, it is always present. This is why I always like defensive growth plays. Canadian healthcare stock Well Health Technologies (TSX:WELL) is my favourite one today.

Please read on as I go over the reasons for my positive outlook for this healthcare stock that’s rapidly growing.

Stethoscope with dollar shaped cord

Source: Getty Images

Well Health stock: volatile but defensive

I’d like to start off by pointing out that at first glance, it might appear that Well Health Technologies stock is not defensive at all. If we look at a graph of its stock price, we can see why one could easily arrive at that conclusion.

But I would caution against that because that would potentially eliminate this stock from consideration. The fact is that Well Health is a company that is in the beginning stages of its growth. This means that, by definition, there will be some heightened volatility and uncertainty. It’s the normal growth process even of companies that are, by their very nature, defensive, like Well Health Technologies.

A growth stock in a defensive industry

Since 2020, Well Health has grown its revenue by 1,700% to $920 million in 2024. Although the company was still operating at a loss in its latest quarter, cash flows are increasing, setting the stage for further growth.

Well Health develops technology, services, and support functions in pursuit of its mission to tech-enable healthcare providers. Demand for this has been booming and continues to be exceptionally strong. Understandably, the healthcare industry is in dire need of the efficiencies that Well Health offers in order to improve care, reduce costs, and lessen the burden.

The biggest issue for Well Health has been focusing and consolidating its business. Demand has been booming from the start, but in an emerging industry, we should always expect there to be growing pains.

In Well Health’s case, this has manifested in its struggle to maintain positive earnings. In its latest quarter, revenue increased 32% to $294.1 million, driven by organic growth and acquisitions. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) rose 36% to $27.6 million. Yet, the company posted a net loss of $41.9 million. The good news is that this loss was due to one-time issues. Adjusted net income was $7.5 million. Excluding all one-time events, net income improved by $2.6 million versus last year.

This is messy. It causes investors to understandably shy away from a stock. But let me tell you more of the facts that lead to my bullish view on this Canadian healthcare stock that’s bringing technology to the healthcare sector.

Upcoming divestitures and a clear focus

Well Health’s strategy is to divest its care delivery clinics in the U.S. within the next two years. This means that the company’s Circle Medical and WISP businesses are up for sale. With the proceeds of these sales, Well Health will have a clear focus, concentrating on the following four areas: its Canadian clinic network, Well Star, Cyberwell, and Healwell.

The Canadian clinic network is Well Health’s primary focus. This network currently consists of 220 Well Health-owned clinics, which is only 1% of total clinics. Hence, the opportunity here is large. Well Health’s goal is to capture 10% of the market, which equates to more than $5 billion in revenue. The Canadian clinic network currently generates $500 million in annual revenue for Well Health.

Other areas of focus include Well Star, which is a provider of tech solutions, CyberWell, which provides cybersecurity, and HealWell, which is using artificial intelligence and data science in order to improve disease detection, management, and care.

The bottom line

Healthcare spending is as defensive as it gets. Spending on technology to make everyone’s life easier and better in the healthcare realm is also as defensive as it gets. Well Health Technologies is gearing up to do all that and more. It is my defensive growth stock of choice.

Fool contributor Karen Thomas has a position in Well Health Technologies. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Tech Stocks

IonQ stock surged in early august 2026
Tech Stocks

Why IonQ Stock Is Up 16% This Week

IonQ is the biggest and best-funded pure play on quantum computing -- and this investment bank loves it.

Read more »

senior relaxes in hammock with e-book
Dividend Stocks

A Canadian Dividend Stock Down 59% to Buy and Hold for Retirement

BCE’s “boring” dividend reputation cracked, but a reset payout and a turnaround plan could still interest retirees.

Read more »

u.s. government spending
Tech Stocks

Which Quantum Computing Stocks Get the Most U.S. Government Funding – and Does It Matter?

The Pentagon spent US$151 million on quantum computing. Investors who chased those headlines probably wish they hadn't.

Read more »

A child pretends to blast off into space.
Tech Stocks

2 Canadian Stocks That Could Surge Before 2026 Ends

Two smaller Canadian growth stocks could get a boost from upcoming results and big deals tied to data-centre power and…

Read more »

moving into apartment
Tech Stocks

Canada’s Smart Money Is Piling Into This TSX Leader

Major institutional investors are loading up on this Canadian tech stock after blowout growth. Here is why the smart money…

Read more »

man in bowtie poses with abacus
Dividend Stocks

What the Average Canadian TFSA Looks Like at Age 50

See what the average Canadian TFSA looks like at age 50 and how CNR, Constellation Software, and VFV could support…

Read more »

Senior uses a laptop computer
Dividend Stocks

A Canadian Dividend Stock Down 35% to Buy and Hold for Retirement

Rogers’ 13% dip has pushed its yield above 4%, and management expects a big jump in free cash flow.

Read more »

A patient takes medicine out of a daily pill box.
Tech Stocks

1 Undervalued Canadian Stock to Buy and Hold Forever

This small-cap healthcare software stock keeps winning long-term contracts and just got a governance stamp of approval.

Read more »